StockData
Cerenome, Inc. logo

Cerenome, Inc. (CNSY) stock

CNSYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/3071% below fair value
$0.63−0.08 (-11.82%)

Close on Nov 17, 2026Market cap $4.78MP/E –Yield –

Cerenome gross margin

Gross margin is gross profit as a percentage of revenue.

Cerenome's gross margin for the twelve months ending Mar 31, 2018 was 15.0%. For fiscal 2018 it was 68.7%, against 5.4% the year before. The highest annual figure on record is 68.7% in fiscal 2018.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2018Dec 31, 201868.7%+63.3
FY2017Dec 31, 20175.4%−36.3
FY2016Dec 31, 201641.7%+7.5
FY2015Dec 31, 201534.1%−6.5
FY2014Dec 31, 201440.6%−11.3
FY2013Dec 31, 201352.0%−2.1
FY2012Dec 31, 201254.1%+2.1
FY2011Dec 31, 201151.9%−0.7
FY2010Dec 31, 201052.7%+10.8
FY2009Dec 31, 200941.9%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2018Mar 31, 201820.8%+41.9
Q4 FY2017Dec 31, 20174.4%−31.2
Q3 FY2017Sep 30, 2017-4.3%−19.7
Q2 FY2017Jun 30, 201727.0%−21.0
Q1 FY2017Mar 31, 2017-21.2%–
Q4 FY2016Dec 31, 201635.5%–
Q3 FY2016Sep 30, 201615.5%–
Q2 FY2016Jun 30, 201648.0%–

More Cerenome figures

See a number that looks wrong?